← Back to Search

Behavioural Intervention

CI Therapy for Stroke-related Arm Weakness

N/A

Waitlist Available

Research Sponsored by University of Alabama at Birmingham

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

At least 6 months after stroke

Ability to demonstrate minimum movement criteria of more-affected UE including 10 degrees of wrist extension (starting from a fully flexed position), 10 degrees of thumb abduction, and 10 degrees of extension of two additional fingers at all joints

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3 months after the end of the treatment.

Awards & highlights

Study Summary

This trial will explore whether a condensed version of CI therapy can be just as effective as the original protocol while being more time/resource friendly.

Who is the study for?

This trial is for stroke survivors who've had a stroke at least 6 months ago and have significant weakness in one arm. They must be able to move their wrist, thumb, and fingers just a little bit and can't have severe cognitive impairments or be unable to consent.Check my eligibility

What is being tested?

The study tests a modified Constraint-Induced Movement Therapy (CI therapy) protocol that fits insurance policies better by reducing therapist time. It involves intensive training, behavioral strategies, and restraint of the stronger arm to improve use of the weaker arm.See study design

What are the potential side effects?

While not explicitly stated, potential side effects may include muscle fatigue, discomfort from restraining the stronger limb, frustration or emotional distress due to intensive practice requirements.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

It has been over 6 months since my stroke.

Select...

I can move my wrist, thumb, and two fingers at least a little bit.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3 months after the end of the treatment.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3 months after the end of the treatment.

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months after the end of the treatment. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Canadian Occupational Performance Measure (COPM)

Motor Activity Log (MAL)

Wolf Motor Function Test (WMFT)

Secondary outcome measures

Stroke Impact Scale (SIS)

Zung Self-Rating Depression Scale

Trial Design

1Treatment groups

Experimental Treatment

Group I: Keys interventionExperimental Treatment1 Intervention

All participants will receive the Keys CI Therapy protocol over an 8-week intervention period.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Keys Constraint-induced Movement Therapy protocol

2022

N/A

~10

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of Alabama at BirminghamLead Sponsor

1,581 Previous Clinical Trials

2,278,019 Total Patients Enrolled

36 Trials studying Stroke

87,374 Patients Enrolled for Stroke

Media Library

Keys Constraint-induced Movement Therapy protocol (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05311384 — N/A

Stroke Research Study Groups: Keys intervention

Stroke Clinical Trial 2023: Keys Constraint-induced Movement Therapy protocol Highlights & Side Effects. Trial Name: NCT05311384 — N/A

Keys Constraint-induced Movement Therapy protocol (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05311384 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the upper limit to the number of people who can join this research project?

"That is correct, a quick glance at the information provided on clinicaltrials.gov reveals that this trial is still recruiting patients. The first posting was on 4/20/2022 and the most recent update was on 5/6/2022. Presently, the trial needs 16 patients from 1 locations."

Answered by AI